ArticleTherapeutic advances in medical oncology2026

Efficacy and safety of PARP inhibitors in metastatic breast cancer patients with homologous recombination repair pathway gene mutations: a retrospective multicenter real-world study.

Xuenan Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.